MedTrace Logo

Persistent Dyspnea in Post COVID_19 and Pulmonary Function

NCT05228678 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2022-02-23

No results posted yet for this study

Summary

COVID-19 has a high spread rate, millions of people have been infected around the world. Patients complained of different symptoms as fever, dry cough and fatigue which is mild in about 80% of cases, but the severity of the case may progress to develop a respiratory distress or respiratory failure, which may require the need for intensive care unit (ICU)

Conditions

  • covid_19 Patients

Interventions

DIAGNOSTIC_TEST

cardiopulmonary exercise tests

Spirometry * forced expiratory volume in 1 second (FEV1) % predicted, * forced vital capacity (FVC)% predicted, * forced expiratory volume in 1 second /forced vital capacity FEV1 /FVC

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2023-10-01
Completion
2024-04-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05228678 on ClinicalTrials.gov